GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Balchem Corp (NAS:BCPC) » Definitions » Cash Flow from Operations

BCPC (Balchem) Cash Flow from Operations : $185.1 Mil (TTM As of Mar. 2025)


View and export this data going back to 1986. Start your Free Trial

What is Balchem Cash Flow from Operations?

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

For the three months ended in Mar. 2025, Balchem's Net Income From Continuing Operations was $37.1 Mil. Its Depreciation, Depletion and Amortization was $11.0 Mil. Its Change In Working Capital was $-15.3 Mil. Its cash flow from deferred tax was $-0.1 Mil. Its Cash from Discontinued Operating Activities was $0.0 Mil. Its Asset Impairment Charge was $0.0 Mil. Its Stock Based Compensation was $3.8 Mil. And its Cash Flow from Others was $0.0 Mil. In all, Balchem's Cash Flow from Operations for the three months ended in Mar. 2025 was $36.5 Mil.


Balchem Cash Flow from Operations Historical Data

The historical data trend for Balchem's Cash Flow from Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Balchem Cash Flow from Operations Chart

Balchem Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only 150.49 160.51 138.54 183.76 182.00

Balchem Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow from Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.39 44.99 51.30 52.32 36.46

Balchem Cash Flow from Operations Calculation

Cash flow from operations refers to the cash brought in through a company's normal business operations. It is the cash flow before any investment or financing activities. It is the cash version of net income.

Balchem's Cash Flow from Operations for the fiscal year that ended in Dec. 2024 is calculated as:

Balchem's Cash Flow from Operations for the quarter that ended in Mar. 2025 is:


Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $185.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Balchem  (NAS:BCPC) Cash Flow from Operations Explanation

For companies reported in indirect method, cash flow from operations contains six items:

1. Net Income From Continuing Operations:
Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Balchem's net income from continuing operations for the three months ended in Mar. 2025 was $37.1 Mil.

2. Depreciation, Depletion and Amortization:
Depreciation is a present expense that accounts for the past cost of an asset that is now providing benefits.
Depletion and amortization are synonyms for depreciation.
Generally:
The term depreciation is used when discussing man made tangible assets
The term depletion is used when discussing natural tangible assets
The term amortization is used when discussing intangible assets

Balchem's depreciation, depletion and amortization for the three months ended in Mar. 2025 was $11.0 Mil.

3. Change In Working Capital:
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities. Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow.

Balchem's change in working capital for the three months ended in Mar. 2025 was $-15.3 Mil. It means Balchem's working capital declined by $15.3 Mil from Dec. 2024 to Mar. 2025 .

4. Deferred Tax:
It is the cash flow generated from deferred tax.

Balchem's cash flow from deferred tax for the three months ended in Mar. 2025 was $-0.1 Mil.

5. Cash from Discontinued Operating Activities:
Net cash from all of the entity's discontinued operating activities.

Balchem's cash from discontinued operating Activities for the three months ended in Mar. 2025 was $0.0 Mil.

6. Asset Impairment Charge:
It is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Balchem's asset impairment charge for the three months ended in Mar. 2025 was $0.0 Mil.

7. Stock Based Compensation:
It is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Balchem's stock based compensation for the three months ended in Mar. 2025 was $3.8 Mil.

8. Cash Flow from Others:
These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Balchem's cash flow from others for the three months ended in Mar. 2025 was $0.0 Mil.


Balchem Cash Flow from Operations Related Terms

Thank you for viewing the detailed overview of Balchem's Cash Flow from Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Balchem Business Description

Traded in Other Exchanges
Address
5 Paragon Drive, Montvale, NJ, USA, 07645
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
Executives
Van Gunsteren Job Leonard officer: Vice President 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
William A. Backus officer: Chief Accounting Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Michael Robert Sestrick officer: Chief Technology Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
David B Fischer director 425 WINTER ROAD, DELAWARE OH 43015
Michael Bent Tignor officer: Chief Human Resources Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Matthew David Wineinger director 3605 GRAND VIEW COURT, ST CHARLES IL 60175
Theodore L Harris director, officer: President and CEO 5200 BLAZER PARKWAY, DUBLIN OH 43017
Olivier Rigaud director CORBION NV, PIET HEINKADE 127, AMSTERDAM P7 1019 GM
Monica Vicente director C/O FRESH DEL MONTE PRODUCE INC., P.O. BOX 149222, CORAL GABLES FL 33114
Frederic Boned officer: SVP/GM, Human Nutri. & Health 5 PARAGON DRIVE, MONTVALE NJ 07645
Hatsuki Miyata officer: General Counsel and Secretary 5 PARAGON DRIVE, MONTVALE NJ 07645
Jonathan Harrison Griffin officer: Vice President 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Martin Luther Reid officer: Chief Supply Chain Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Kathleen B Fish director ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
James C Hyde officer: Sr. Vice President 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958